首页> 外文期刊>Medical acupuncture >NADA Ear Acupuncture for Breast Cancer Treatment-Related Hot Flashes and Night Sweats: An Observational Study
【24h】

NADA Ear Acupuncture for Breast Cancer Treatment-Related Hot Flashes and Night Sweats: An Observational Study

机译:NADA针灸治疗与乳腺癌相关的潮热和夜间盗汗的观察性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Hot flashes and night sweats (HF&NS) are major side-effects of adjuvant hormonal treatments for breast cancer.Objective: The aim of this study was to evaluate the feasibility of the National Acupuncture Detoxification Association (NADA) five-point ear acupuncture protocol to reduce HF&NS and improve physical and emotional well-being for women receiving adjuvant treatments for breast cancer. Design: This trial was a single-arm observational study that used before-and-after measurements. Setting: The trial was conducted at a National Health Service cancer treatment center in southern England. Patients: The subjects included women with early breast cancer, > 35 years old, > 6 months post-active cancer treatment, receiving tamoxifen >6 months, and self-reporting >4 HF&NS incidents/24-hours for > 3 months. Intervention: Fifty participants completed weekly NADA treatment for 8 weeks in small groups of <5 patients. Main Outcome Measures: The factors examined were changes in scores at end of treatment over baseline for HF&NS frequency, physical, and emotional well-being, and perception of HF&NS as a problem. Results: Mean HF&NS frequency was reduced by 35.9% (95% confidence interval: 25.4-45.4, p< 0.0001, 72 = 47). Statistical and clinical improvements were recorded for Anxiety/Fears, Depressed Mood, Memory/ Concentration, Sleep Problems, Somatic Symptoms, and Vasomotor Symptoms. Perceptions of HF&NS as a problem were reduced by 2.2 points (standard deviation = 2.23, n = 48, £ = 7.22, /?<0.0001). Conclusions: NADA ear acupuncture may be a simple nonpharmacological method of managing breast-cancer treatment-related HF&NS.
机译:背景:潮热和盗汗是乳腺癌辅助激素治疗的主要副作用。目的:本研究的目的是评估美国针灸排毒协会(NADA)五点耳针疗法的可行性。减少接受乳腺癌辅助治疗的妇女的HF&NS,并改善他们的身心健康。设计:该试验是一项单臂观察性研究,使用了前后测量。地点:该试验在英格兰南部的国家卫生服务中心癌症治疗中心进行。患者:受试者包括患有早期乳腺癌,> 35岁,在积极的癌症治疗后> 6个月,接受他莫昔芬> 6个月和自我报告> 4 HF&NS事件/ 24小时≥3个月的妇女。干预:五十名参与者在<5名患者的小组中完成了为期8周的每周NADA治疗。主要结果指标:检查的因素是治疗结束时HF&NS频率,身体和情绪健康以及对HF&NS的感知程度超过基线的得分变化。结果:HF&NS平均频率降低了35.9%(95%置信区间:25.4-45.4,p <0.0001,72 = 47)。记录了焦虑/恐惧,情绪低落,记忆/注意力,睡眠问题,躯体症状和血管舒缩症状的统计和临床改善。 HF&NS问题的感知减少了2.2点(标准差= 2.23,n = 48,£ = 7.22,/?<0.0001)。结论:NADA耳针可能是一种简单的非药理学方法,用于治疗与乳腺癌相关的HF&NS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号